Evolv业绩 - Evolv是一家AI武器检测领域的领导者，产品已在全球筛查超过6亿名访客[45] - 截至2023年3月31日，Evolv的营收为1.86亿美元，较2022年同期的870万美元有显著增长[46] - 2023年3月31日，Evolv的净亏损为2,860万美元，较2022年同期的1,380万美元有所增加[47] Evolv未来发展 - Evolv预计将继续投入研发，以推动新产品开发和商业化，这可能会对短期盈利能力产生负面影响[56] - 产品销售占Evolv总收入的47%，预计随着更多客户转向全订阅交易，产品销售占比将逐渐下降[52] - Evolv预计未来将加大在美国等地区的产品推广力度，转向更多的全订阅销售模式[53] - Evolv与Columbia Tech签订了分销和许可协议，预计该协议将于2023年第二财季末开始生效[54] 财务状况 - 公司在2023年第一季度实现总收入18581千美元，同比增长113%[76] - 产品收入同比增长69%，达到8754千美元，产品收入毛利率为-21%[77] - 订阅收入同比增长115%，达到6466千美元，订阅收入毛利率为64%[79] - 服务收入同比增长556%，达到3361千美元，服务收入毛利率为74%[81] - 研发费用同比增长29%，达到5389千美元[82] - 销售和营销费用同比增长32%，达到12804千美元[83] - 总体净亏损为28609千美元，同比增长107%[76] 其他 - 公司在2023年第一季度实现利息收入100万美元，主要来自货币市场基金[88] - 公司在2023年第一季度发生的公开认股权证（Public Warrants）的公允价值变动导致损失175万美元[91] - 截至2023年3月31日，公司现金及现金等价物为1.81亿美元[92] - 2023年第一季度公司净亏损为2860万美元，较2022年同期的1380万美元有所增加[96] - 2023年第一季度公司投资活动中，主要用于购买物业和设备，包括购买用于出租的Evolv Express设备[99]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 For the transition period from to Commission file number: 001-39417 EVOLV TECHNOLOGIES HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 84-4473840 (State of Other Jurisdiction of Incorporation or Organization) (I.R.S. Employer Identification No.) 500 Totten Pond Road, ...

Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Q4 2022 Earnings Conference Call March 1, 2023 4:30 PM ET Company Participants Brian Norris - VP, Finance and IR Peter George - CEO Mark Donohue - CFO Conference Call Participants Mike Latimore - Northland Capital Brett Knoblauch - Cantor Fitzgerald Brian Ruttenbur - Imperial Capital Operator -- to the Evolv Technologies Fourth Quarter Earnings Results Conference Call. At this time, all participants are in listen-only mode. Later, we will conduct a question-an ...

Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Q3 2022 Results Earnings Conference Call November 9, 2022 4:30 PM ET Company Participants Brian Norris - Vice President of Finance and Investor Relations Peter George - Chief Executive Officer Mark Donohue - Chief Financial Officer Conference Call Participants Michael Latimore - Northland Capital Markets Alexander Schwartz - Stifel Operator Hello and welcome to the Evolv Technologies Third Quarter Earnings Results Conference Call. At this time, all participant ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to Commission file number: 001-39417 ___________________________________ Evolv Technologies Holdings, Inc. (Exact Name of ...

Table of Contents ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to Commission file number: 001-39417 ___________________________________ Evolv Technologies Holdings, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 OR (Exact Name of Regi ...

Call Start: 16:30 January 1, 0000 5:17 PM ET Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Q2 2022 Earnings Conference Call August 10, 2022 16:30 ET Company Participants Brian Norris - Vice President of Finance & Investor Relations Peter George - Chief Executive Officer Mark Donohue - Chief Financial Officer Conference Call Participants Shaul Eyal - Cowen & Company Mike Latimore - Northland Capital Markets Brian Ruttenbur - Imperial Capital Brad Reback - Stifel Operator Ladies and gentlemen, thank you for ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39417 Evolv Technologies Holdings, Inc. (Exact Name of Registrant as Specified in its Charter) | Delaware | 84-4473840 | ...

Evolv Technologies Holdings, Inc. (NASDAQ:EVLV) Q1 2022 Earnings Conference Call May 11, 2022 4:30 PM ET Company Participants Brian Norris - Vice President, Investor Relations Peter George - Chief Executive Officer Mario Ramos - Chief Financial Officer & Chief Risk Officer Conference Call Participants Mike Latimore - Northland Capital Markets Brad Reback - Stifel Brian Ruttenbur - Imperial Capital Operator Ladies and gentlemen, thank you for standing by. Welcome to the Evolv Technologies' First Quarter Ear ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-39417 EVOLV TECHNOLOGIES HOLDINGS, INC. (Exact name of registrant as specified in its charter) (State of Other Jurisdiction o ...